In this study, we firstly demonstrated that SMAD2 was down-expressed in FLS-RA, and overexpression of SMAD2 can inhibit NLRP3/Caspase-1 pathway, thus attenuating the symptoms in collagen-induced arthritis (CIA) rats. Here, NLRP3 is linked to rheumatoid arthritis.